For agencies and organizations charged with protecting public health, food safety, the environment and economic security, early detection—especially in the field—is a needed capability, one lacking to date.
Draper is developing technology/systems to diagnose and detect natural and engineered pathogens and GMOs. Our portable solutions will deliver accurate results, dramatically accelerating situational awareness. This means better decisions, faster response and more effective allocation of resources.
Biotechnologies Draper is designing for national security biosurveillance have immense promise for use in public health, precision medicine, environmental monitoring, food safety and agricultural export and import controls.
Draper has developed technologies that can detect the presence of nucleic acid signatures from a variety of sources. The technologies are currently being developed for the detection of nucleic acid signatures from environmental and clinical samples. When combined with the accompanying bioinformatics, the technologies can look for the presence or absence of a signature from a sample and if needed, determine if the signature is from a GMO.
Our miniaturized microarray in conjunction with the downstream pipeline can identify a genetically engineered microbe within a sample containing thousands of natural organisms.